Hannah Brown

Hannah Brown

Company: Boston University (Researcher for Phase 3 Adjunctive KarXT trial)

Job title: Clinical Associate Professor, Psychiatry

Seminars:

Innovation in Compliance: Earlier Initiation of Long-Acting Injectables to Avoid Relapse & Improve Patient Outcomes 12:00 pm

Leveraging long-acting injectables (LAIs) as an early intervention to address non-compliance in psychosis treatment, advanced delivery systems, and patient-centric solutions Highlighting the benefits of early LAI initiation, improved side-effect profiles To reduce relapses, prevent chronicity, and improve treatment outcomes by minimizing the biological and psychological impacts of non-compliance, fostering better patient experiences, and advancing long-term…Read more

day: Day One

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.